Development
Tarsus Pharmaceuticals, Inc.
TARS
$41.64
$0.491.19%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.80% | 8.97% | -27.36% | 14.78% | 26.31% |
| Total Receivables | 394.53% | 58.77% | -60.32% | 803.41% | 3,793.48% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 65.05% | 71.92% | 16.33% | 44.01% | 17.85% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 13.65% | 10.77% | -26.69% | 16.72% | 28.09% |
|
|
|||||
| Total Current Assets | 13.65% | 10.77% | -26.69% | 16.72% | 28.09% |
| Net Property, Plant & Equipment | 118.54% | 120.10% | 107.09% | -5.87% | -16.24% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 217.40% | 250.15% | 299.40% | -50.62% | 3.02% |
| Total Assets | 16.51% | 13.48% | -25.27% | 16.38% | 27.36% |
|
|
|||||
| Total Accounts Payable | 230.10% | 85.66% | 99.66% | 87.84% | 92.51% |
| Total Accrued Expenses | 46.82% | 7.05% | -12.22% | -35.58% | 26.84% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -44.80% | -26.05% | -28.76% | 10.71% | 18.39% |
| Total Finance Division Other Current Liabilities | -- | 26,885.71% | -- | -93.89% | -- |
| Total Other Current Liabilities | -- | 26,885.71% | -- | -93.89% | -- |
| Total Current Liabilities | 139.39% | 62.89% | 26.00% | 5.11% | 34.42% |
|
|
|||||
| Total Current Liabilities | 139.39% | 62.89% | 26.00% | 5.11% | 34.42% |
| Long-Term Debt | 53.44% | 53.48% | 27.75% | 27.82% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 886.39% | 505.00% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 133.00% | 10.00% | -74.42% | -43.66% | -12.28% |
| Total Liabilities | 95.93% | 61.56% | 31.53% | 17.11% | 187.12% |
|
|
|||||
| Common Stock & APIC | 46.37% | 39.83% | 5.85% | 41.44% | 41.39% |
| Retained Earnings | -124.94% | -113.06% | -125.19% | -97.55% | -133.04% |
| Treasury Stock & Other | 97.30% | 20.00% | -- | -- | -- |
| Total Common Equity | 2.12% | 5.45% | -33.31% | 16.22% | 15.70% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.12% | 5.45% | -33.31% | 16.22% | 15.70% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.12% | 5.45% | -33.31% | 16.22% | 15.70% |
|
|
|||||